« Back to Record
Citation APA

Roy, D. C., Walker, I., Maertens, J., Lewalle, P., Olavarria, E., Selleslag, D., Lachance, S., Buyse, M., Wang, K., Rovers, J., Santi, I., Bonig, H., Sandler, A., Velthuis, J. H. L., & Mielke, S. (2020). ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia. Leukemia. doi:10.1038/s41375-020-0733-0


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/305065

Roy, D. C., Walker, I., Maertens, J., Lewalle, P., Olavarria, E., Selleslag, D., Lachance, S., Buyse, M., Wang, K., Rovers, J., Santi, I., Bonig, H., Sandler, A., Velthuis, J. H. L., & Mielke, S. (2020). ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia. Leukemia. doi:10.1038/s41375-020-0733-0